Physician profile
Ariel L Botwin
NPI 1447754577
$1,674.21
in general payments reported to CMS, 2019-2025
7 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $628 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279 · Travel and Lodging: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.79 |
| Travel and Lodging | $395.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $589.05 | 2025 | Augment Injectable, Flowtriever, Venacore Thrombectomy Catheter |
| Penumbra, INC. | $351.42 | 2024-2025 | Ruby Coil, Indigo System |
| Medtronic, INC. | $246.02 | 2024-2025 | Mvp, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $202.71 | 2024-2025 | Spaceoar Vue System - 10ml, Percuflex Nephroureteral Stent |
| Sirtex Medical INC | $200.15 | 2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Inari Medical, INC. | $65.15 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mozarc Medical US LLC | $19.71 | 2025 | Palindrome |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Botwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.